Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/SrHZn8CyUdw/251683.php
Monday, 22 October 2012
'ACT TIL' Approach Studied For The Treatment Of Metastatic Melanoma
Researchers at Moffitt Cancer Center have carried out a clinical trial in which patients with metastatic melanoma were given chemotherapy and an immunotherapy of adoptive cell transfer (ACT) with tumor infiltrating lymphocytes (TIL). Tumor tissues were surgically removed from patients, minced and grown in culture. The treatment combined chemotherapy, then ACT with TIL, followed by interleukin-2 (IL-2). The combination therapy drew a high response rate from some patients. The study appears in the October issue of the Journal of Immunotherapy...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment